Gilead Science Korea said its hepatitis B treatment Vemlidy (Ingredient: tenofovir alafenamide) started receiving expanded health insurance coverage for treating patients with decompensated cirrhosis and hepatitis B with hepatocellular carcinoma on Sunday.The government expanded the reimbursement st
Aphrodite Acquisition Holdings has completed the stock purchase agreement (SPA) with Leguh Issuer Designated Activity Company (LIDAC), the former largest shareholder of Hugel, a botulinum toxin product maker.Hugel’s shareholders approved it at an extraordinary meeting at the company headquarters in
GC said it has entered into a development and option agreement with Acuitas Therapeutics, a Canada-based company, by licensing in the latter's lipid nanoparticle (LNP) delivery system.Under the accord, GC will use up to four LNP technologies owned by Acuitas to develop messenger RNA (mRNA) vaccines
The government will end the 18-month-long outdoor mask mandate following Monday, Prime Minister Kim Boo-kyum said.However, Koreans will have to wear a mask at gatherings, performances, and sports events where more than 50 people gather because these places have a high risk of infection. The governme
Vivozon Pharmaceuticals said that it has received a final administrative disposition from the Ministry of Food and Drug Safety for 26 drug manufacturing violations.The regulatory disposition comes after the ministry suspended the making and selling of products made by Vivozon and ordered their recal
Daewoong Pharmaceutical said it signed a license-out and cooperation contract with AstraZeneca Korea for Crezet, its hyperlipidemia treatment, in four Asian countries -- Indonesia, Thailand, Malaysia, and the Philippines.Under the accord, the two companies plan to apply for local licenses for Crezet
Seoul National University Hospital and Seoul Medical University will start developing a portable hemodialysis device and filter together with HealthConnect, Synopex, and Bayada Home Health Care.Hemodialysis, which accounts for more than 80 percent of all renal replacement therapies, is a treatment t
The conflict between President Moon Jae-in and President-elect Yoon Suk-yeol continues 12 days before the new government's inauguration.The problem is that it is not only political conflicts between the two administrations but also the ongoing proxy war regarding the current quarantine policies.Yoon
LG Chem said that it has signed a local joint sales contract with Kyowa Kirin Korea for Nesp and Regpara, its chronic kidney disease (CKD) treatments.Under the accord, LG Chem will operate at the clinic and hospital level, while Kyowa Kirin Korea will operate at the general hospital level.LG Chem pl
Samsung Biologics said that it achieved the highest quarterly performance ever in the first quarter by posting 511.3 billion won ($401.6 million) in sales in the first quarter of this year, up 96 percent from the same period in 2021.The company also registered 176.4 billion won in operating profit,
Helixmith said it has signed a three-party memorandum of understanding with Cartexell and GI Cell for joint research on cell gene therapy products.The trilateral MOU will encourage cooperation between the three companies to identify candidate materials for cell gene therapy and cooperate in manufact
Korea is regarded as one of the most “hip” countries. The popularity of K-pop, K-drama, K-movie, K-food, and even K-beauty is growing worldwide.This is more surprising because the nation was in a war 70 years ago and one of the poorest countries 60 years ago.The term “Miracle on the Han River,” refe
Researchers at Seoul National University Hospital have developed a simple method to predict the risk of heart failure in patients with hypertrophic cardiomyopathy.According to the hospital, people with hypertrophic cardiomyopathy need to take special care as it can lead to end-stage heart failure. H
President-elect Yoon Suk-yeol's transition committee said Wednesday that the new government would determine whether to remove the outdoor mask mandate toward the end of May.The transition team also said it plans to secure hospital beds and manpower to prepare for a possible resurge of Covid-19, prep
Labor union members of Sanofi Aventis Korea, the offshoot of the French-based multinational pharmaceutical company, have filed a lawsuit against the company's general manager and human resources head for failing to pay overtime allowances.The union filed a lawsuit on behalf of four of its members on
AT Sens said that it has signed a contract with Al Dabbous Medical Company, a Kuwait-based medical device distributor, to export AT-Patch, a continuous, long-term use electrocardiogram (ECG) device.Under the accord, AT Sens will export about 3 billion won ($2.4 million) worth of AT-Patch to Al Dabbo
Celltrion said that it recently completed a patent agreement with AbbVie, the developer of the blockbuster autoimmune disease treatment Humira (Ingredient: adalimumab), and will start selling its biosimilar version, Yuflyma, in the U.S. from July 2023.Celltrion applied Yuflyma to the U.S. Food and D
Pfizer Korea aims to strengthen its position in the local dermatology market with the launch of its first dermatology product Cibinqo (ingredient: abrocitinib), a treatment for moderate to severe atopic dermatitis, the company said.Cibinqo is a Janus kinase 1 (JAK1) inhibitor released in Korea on Ap
As the Omicron wave has notably slowed down, the quarantine authorities have downgraded the national Covid-19 risk from high to medium level for the first time in 14 weeks.The assessment divides the risk of Covid-19 infection into five levels -- very low, low, medium, high, and very high – by evalua
Transgene, Sillajen’s EU partner, published the result of using Pexa-Vec, an oncolytic virus therapy, as preoperative therapy for nine patients with either colorectal cancer liver metastases or metastatic melanoma scheduled for surgery.The company conducted the clinical trial from September 2015 to